Atara Biotherapeutics, Inc. financial data

Symbol
ATRA on Nasdaq
Location
1280 Rancho Conejo Blvd, Thousand Oaks, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 62.9 % +8.79%
Quick Ratio 4.95 % -46.9%
Debt-to-equity -206 % +16.8%
Return On Equity -41.8 % -131%
Return On Assets 39.3 %
Operating Margin 17.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.21M shares +25.2%
Common Stock, Shares, Outstanding 7.21M shares +25.6%
Entity Public Float 41M USD -74.6%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 13.6M shares +81.7%
Weighted Average Number of Shares Outstanding, Diluted 13.6M shares +81.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 152M USD -91.4%
Research and Development Expense 66.4M USD -61.5%
General and Administrative Expense 31.4M USD -25%
Costs and Expenses 126M USD -45.7%
Operating Income (Loss) 26.2M USD +83.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 23.4M USD +80.5%
Income Tax Expense (Benefit) 12K USD -33.3%
Net Income (Loss) Attributable to Parent 23.4M USD +80.4%
Earnings Per Share, Basic 3 USD/shares +89.1%
Earnings Per Share, Diluted 3 USD/shares +89.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.74M USD -87.6%
Accounts Receivable, after Allowance for Credit Loss, Current 1.91M USD +43.3%
Inventory, Net 0 USD -100%
Other Assets, Current 2.81M USD -69.5%
Assets, Current 18.4M USD -79.9%
Property, Plant and Equipment, Net 147K USD -91.2%
Operating Lease, Right-of-Use Asset 10.7M USD -76.6%
Other Assets, Noncurrent 881K USD -73.8%
Assets 30.2M USD -78.9%
Accounts Payable, Current 318K USD -85.2%
Employee-related Liabilities, Current 2.07M USD -73.4%
Accrued Liabilities, Current 2.55M USD -68.3%
Contract with Customer, Liability, Current 77.8M USD
Liabilities, Current 18.1M USD -88.4%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 15M USD -57.4%
Other Liabilities, Noncurrent 1.76M USD -55.6%
Liabilities 66.8M USD -71.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2K USD -90.9%
Retained Earnings (Accumulated Deficit) -2.02B USD +1.15%
Stockholders' Equity Attributable to Parent -36.6M USD +59.5%
Liabilities and Equity 30.2M USD -78.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.1M USD +4.98%
Net Cash Provided by (Used in) Financing Activities -250K USD -101%
Net Cash Provided by (Used in) Investing Activities 17.2M USD +16.9%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 7.21M shares +25.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.74M USD -87.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 66K USD -42.1%
Deferred Tax Assets, Valuation Allowance 368M USD -22.4%
Deferred Tax Assets, Gross 377M USD -22.5%
Operating Lease, Liability 17M USD
Depreciation 300K USD -91.9%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 23.4M USD +80.3%
Lessee, Operating Lease, Liability, to be Paid 23.3M USD
Property, Plant and Equipment, Gross 551K USD -97.2%
Operating Lease, Liability, Current 1.95M USD -85.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.26M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.02M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure -17.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.32M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.23M USD
Deferred Tax Assets, Operating Loss Carryforwards 259M USD -19.8%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 37.9M USD -76.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.32M USD
Operating Lease, Payments 4.14M USD +3.66%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 8.75M USD -24.6%
Share-based Payment Arrangement, Expense 14.1M USD -54.7%
Interest Expense 3.92M USD -18%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%